apceth Biopharma Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
153
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
apceth Biopharma General Information
Description
Developer of stem cell-based therapies intended for the treatment of malignant and non-malignant diseases. The company offers comprehensive contract GMP services for clinical and commercial stage Advanced Therapy Medicinal Products (ATMPs), enabling health community to get access to treatment of clinical conditions for which no satisfactory treatment options are available to date.
Contact Information
Website
www.apceth.comCorporate Office
- Max-Lebsche-Platz 30
- 81377 Munich
- Germany
Corporate Office
- Max-Lebsche-Platz 30
- 81377 Munich
- Germany
apceth Biopharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
apceth Biopharma Comparisons
Industry
Financing
Details
apceth Biopharma Competitors (60)
One of apceth Biopharma’s 60 competitors is Regenxbio, a Formerly VC-backed company based in Rockville, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Regenxbio | Formerly VC-backed | Rockville, MD | ||||
| Adverum Biotechnologies | Formerly VC-backed | Redwood City, CA | ||||
| MeiraGTx | Formerly VC-backed | New York, NY | ||||
| CSL Behring (Biotechnology) | Corporation | Vienna, Austria | ||||
| Kedrion | Private Equity-Backed | Barga, Italy |
apceth Biopharma Patents
apceth Biopharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2017242899-A1 | Mesenchymal stem cells to enhance anti-tumor activity of immunotherapy | Inactive | 01-Apr-2016 | ||
| AU-2023237078-A1 | Mesenchymal stem cells to enhance anti-tumor activity of immunotherapy | Inactive | 01-Apr-2016 | ||
| WO-2017167959-A1 | Mesenchymal stem cells to enhance anti-tumor activity of immunotherapy | Inactive | 01-Apr-2016 | ||
| WO-2017036925-A1 | Mesenchymal stem cells for the treatment of metastatic liver disease | Inactive | 28-Aug-2015 | ||
| WO-2016146819-A1 | Hypoxia-induced expression of therapeutic proteins in mesenchymal stem cells | Inactive | 18-Mar-2015 | C12N5/0663 |
apceth Biopharma Signals
apceth Biopharma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
apceth Biopharma FAQs
-
When was apceth Biopharma founded?
apceth Biopharma was founded in 2007.
-
Where is apceth Biopharma headquartered?
apceth Biopharma is headquartered in Munich, Germany.
-
What is the size of apceth Biopharma?
apceth Biopharma has 153 total employees.
-
What industry is apceth Biopharma in?
apceth Biopharma’s primary industry is Biotechnology.
-
Is apceth Biopharma a private or public company?
apceth Biopharma is a Private company.
-
What is apceth Biopharma’s current revenue?
The current revenue for apceth Biopharma is .
-
Who are apceth Biopharma’s investors?
Bundesministerium für Bildung und Forschung has invested in apceth Biopharma.
-
Who are apceth Biopharma’s competitors?
Regenxbio, Adverum Biotechnologies, MeiraGTx, CSL Behring (Biotechnology), and Kedrion are some of the 60 competitors of apceth Biopharma.
-
When was apceth Biopharma acquired?
apceth Biopharma was acquired on 03-Apr-2019.
-
Who acquired apceth Biopharma?
apceth Biopharma was acquired by Showa Denko Materials.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process